Prospective study on long term risk of hormone replacement therapy

Chapters in this book

1. Frontmatter I
2. Contents V
3. Opening remarks 1
4. Prologue 3
5. 1. Physiology and pathophysiology of the perimenopausal years
6. Some aspects of oogenesis, follicular growth, and endocrine involution 11
7. The climacteric syndrome 39
8. Skin and the menopause 57
9. Osteoporosis: occurrence and diagnosis 69
10. Lipids, hormonal status and the cardiovascular system in the postmenopause 77
11. Psychosocial aspects in the perimenopause 87
12. The bladder in the menopausal woman 93
13. Discussion 103
14. 2. Management of the climacteric patient
15. 2.1. General aspects
16. The influence of nutrition and exercise 109
17. Non-hormonal medication 117
18. Discussion 126
19. 2.2. Hormonal treatment
20. Selection of patients — kind and duration of treatment 129
21. Routes of estrogen administration 141
22. Sex steroids and lipoproteins 149
23. Discussion 153
24. 2.3. Risk-benefit evaluation of hormonal therapy
25. Prospective study on long term risk of hormone replacement therapy 157
26. Long-term metabolic effects of estrogen therapy 163
27. Hormonal replacement therapy and breast cancer 177
28. Prevention of endometrial abnormalities 189
29. Estrogen/progestogen as a prophylactic treatment of postmenopausal osteoporosis 207
30. Discussion 213
31. 2.4. Special aspects in premenopausal women
32. Management of the premenstrual syndrome 221
33. Contraception in premenopausal age 233
34. Discussion 249
35. Closing remarks 251
36. Epilogue 253
37. List of contributors 255
38. Backmatter 257